LV10917B - New use of bambuterol - Google Patents

New use of bambuterol Download PDF

Info

Publication number
LV10917B
LV10917B LVP-93-816A LV930816A LV10917B LV 10917 B LV10917 B LV 10917B LV 930816 A LV930816 A LV 930816A LV 10917 B LV10917 B LV 10917B
Authority
LV
Latvia
Prior art keywords
bambuterine
lipid
lowering
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
LVP-93-816A
Other languages
English (en)
Latvian (lv)
Other versions
LV10917A (lv
Inventor
Bauer Carl-Axel
Svensson Leif-Ake
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10917A publication Critical patent/LV10917A/xx
Publication of LV10917B publication Critical patent/LV10917B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-93-816A 1990-03-16 1993-06-30 New use of bambuterol LV10917B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use
PCT/SE1991/000195 WO1991013615A1 (en) 1990-03-16 1991-03-14 New use of bambuterol

Publications (2)

Publication Number Publication Date
LV10917A LV10917A (lv) 1995-12-20
LV10917B true LV10917B (en) 1996-04-20

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-816A LV10917B (en) 1990-03-16 1993-06-30 New use of bambuterol

Country Status (28)

Country Link
US (2) US5837727A (ko)
EP (1) EP0521967B1 (ko)
JP (1) JP3081640B2 (ko)
KR (1) KR100194995B1 (ko)
AT (1) ATE138570T1 (ko)
AU (1) AU653149B2 (ko)
CA (1) CA2077762C (ko)
CZ (1) CZ279308B6 (ko)
DE (1) DE69119896T2 (ko)
DK (1) DK0521967T3 (ko)
EG (1) EG19645A (ko)
ES (1) ES2087291T3 (ko)
GR (1) GR3020700T3 (ko)
HK (1) HK52197A (ko)
HU (1) HU211998B (ko)
IE (1) IE80668B1 (ko)
IL (1) IL97509A (ko)
LT (1) LT3734B (ko)
LV (1) LV10917B (ko)
MY (1) MY114218A (ko)
NZ (1) NZ237279A (ko)
PT (1) PT97052B (ko)
RU (1) RU2093153C1 (ko)
SE (1) SE9000948D0 (ko)
SG (1) SG64895A1 (ko)
SK (1) SK278815B6 (ko)
WO (1) WO1991013615A1 (ko)
ZA (1) ZA911452B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
EP1458374A2 (en) * 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
ATE406887T1 (de) * 2002-08-08 2008-09-15 Wen Tan R-bambuterol, seine herstellung und therapeutische verwendungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) * 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
PT97052A (pt) 1991-10-31
MY114218A (en) 2002-09-30
AU7569191A (en) 1991-10-10
DE69119896D1 (de) 1996-07-04
US6034123A (en) 2000-03-07
GR3020700T3 (en) 1996-10-31
CA2077762C (en) 2001-06-12
JPH05504971A (ja) 1993-07-29
LT3734B (en) 1996-02-26
HK52197A (en) 1997-05-02
AU653149B2 (en) 1994-09-22
SK278815B6 (sk) 1998-03-04
JP3081640B2 (ja) 2000-08-28
RU2093153C1 (ru) 1997-10-20
NZ237279A (en) 1993-08-26
WO1991013615A1 (en) 1991-09-19
DK0521967T3 (da) 1996-09-09
ATE138570T1 (de) 1996-06-15
CS9100681A2 (en) 1991-10-15
IE910862A1 (en) 1991-09-25
US5837727A (en) 1998-11-17
SG64895A1 (en) 2000-01-25
EG19645A (en) 1995-09-30
CZ279308B6 (cs) 1995-04-12
DE69119896T2 (de) 1996-10-10
ZA911452B (en) 1991-11-27
KR100194995B1 (ko) 1999-06-15
LTIP1735A (en) 1995-07-25
EP0521967B1 (en) 1996-05-29
SE9000948D0 (sv) 1990-03-16
EP0521967A1 (en) 1993-01-13
ES2087291T3 (es) 1996-07-16
IE80668B1 (en) 1998-11-18
PT97052B (pt) 1998-07-31
CA2077762A1 (en) 1991-09-17
HU211998B (en) 1996-01-29
LV10917A (lv) 1995-12-20
IL97509A0 (en) 1992-06-21
HU9202958D0 (en) 1992-12-28
IL97509A (en) 1995-12-31
HUT61461A (en) 1993-01-28

Similar Documents

Publication Publication Date Title
AU2000249434B2 (en) Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
HK16488A (en) 6(r)-(2-(8'-acyloxy-2'-methyl-6-methyl(or hydrogen)-polyhydronaphthyl-1')-ethyl)-4-(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones,the hydroxy acid form of said pyranones,the pharmaceutically acceptable salts of said hydroxy acids,and the lower alkyl,and phenyl,dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid,processes for preparing the same,and a pharmaceutical antihypercholesterolemic composition containing the same
PL323487A1 (en) Three-phase pharmaceutic form of constant-rate controllable release of amorphous active ingredient for administration once per day
JP2004501121A5 (ko)
NO872259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive trans-6(2-(3-eller 4-karboksamido-substituert-pyrrol-1-yl)alkyl)-4-hydroksypyran-2-on-derivater.
TNSN90003A1 (fr) Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation
LV10917B (en) New use of bambuterol
IL95956A0 (en) Benzoic acid derivatives and pharmaceutical compositions containing the same
ATE8047T1 (de) (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthioessigs[ure, ihre salze und ester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AU8268591A (en) Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions
CA2344053A1 (en) Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
AU3003189A (en) 7(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate ester derivatives
IL70560A (en) Dialkylaminoalkoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them
AU663998B2 (en) Chondroprotective agents
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
CA2310318A1 (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
ATE1855T1 (de) Antiarthritische hydroxyessigsaeurederivate, pharmazeutische zusammensetzungen daraus und verfahren zu ihrer herstellung.
IE41219L (en) Aralkyl esters of aminoalkanoic acids
JPH07507786A (ja) 脂肪酸,例えばz−ヒドロキシミスチン酸の抗ウイルス剤としての使用
DE3765124D1 (de) Neue stickstoffarylmethoxy-thiophenderivate und deren saeureadditionssalze,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
WO1987004435A3 (en) Xanthine compounds
AU4239089A (en) New 1,4-dihydropyridinederivative, namely (-)-2-{(2- aminoethoxy) ethoxy)-4-(2,3-dichlorophenyl)-3- ethoxycarbonyl-50methoxycarbonyl-6-methyl}-1,4- dihydropyridine, process for preparing it and pharmaceutical compositions containing it
NZ241455A (en) Rubidium and caesium salts of diclofenac and pharmaceutical compositions thereof
IT1265108B1 (it) Amidi di acidi biliari, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono